BNP Paribas China Equity vs BGF World Healthscience

BNP Paribas China Equity vs BGF World Healthscience

1. BNP Paribas China Equity

  • Security

    BNP Paribas China Equity Classic USD Cap

  • Fee

    2.23%

  • ISIN

    LU0823426308

  • Holdings

    17

2. BGF World Healthscience

  • Security

    BGF World Healthscience A2

  • Fee

    2.17%

  • ISIN

    LU0122379950

  • Holdings

    10

Fund Holdings

We have information about 18 holdings in BNP Paribas China Equity, where the largest holding is Alibaba Group Holding Ltd (9.68), followed by Tencent (9.52) and Xiaomi (7.33). In comparison with BGF World Healthscience, we have 20 holdings where UnitedHealth is the largest holding (8.2), followed by Eli Lilly (7.01) and Novo Nordisk (6.67).

All Holdings

Here we compare the holdings in BNP Paribas China Equity and BGF World Healthscience.

BNP Paribas China Equity BGF World Healthscience
1. Alibaba Group Holding Ltd
China
9.68 %
1. UnitedHealth Group Inc
USA
8.2 %
2. Tencent Holdings Ltd
China
9.52 %
2. Eli Lilly and Co
USA
7.01 %
3. Xiaomi
China
7.33 %
3. Novo Nordisk B
Denmark
6.67 %
4. Meituan Class B
China
5.29 %
4. Merck & Co Inc
Germany
3.99 %
5. Industrial and Commercial Bank of China Ltd Class H
China
4.58 %
5. Boston Scientific Corp
3.67 %
6. Ping An Insurance Co
China
4.2 %
6. AbbVie Inc
USA
3.61 %
7. JD.com Inc
China
3.02 %
7. Amgen Inc
3.58 %
8. NetEase ADR
China
3.01 %
8. Sanofi SA
France
3.05 %
9. Pinduoduo Inc
China
2.98 %
9. Abbott Laboratories
USA
3.02 %
10. Taiwan Semiconductor Manufacturing Company
Taiwan
2.52 %
10. AstraZeneca
Sweden UK
2.98 %
11. Pop Mart International Group Ltd
China
2.32 %
-
12. Trip.com Group Ltd
Singapore
1.96 %
-
13. KE Holdings Inc ADR
China
1.87 %
-
14. BeiGene Ltd
China
1.61 %
-
15. BYD Co Ltd Class H
China
1.59 %
-
16. Sunny Optical Technology Company Ltd
China
1.53 %
-
17. GDS Holdings Ltd ADR
China
1.22 %
-

The list of fund holdings was last updated on April 17, 2025.